• Novartis in society report
    PDF
    lock
    Publications / Report
    Novartis in Society ESG Report 2019

    Transparent reporting has been a central part of our CR commitment for many years, and we continue to make progress in this area. Our Novartis in Society Report is issued at the same time as our Annual Report to provide readers with a more integrated view of Novartis.

  • Below the map of Africa, a mosquito sits on  an arm. At the bottom of the page eight logos are included: Elimination 8, University  of Oxford, RBM Partnership to End Malaria, Malaria Consortium, Malaria No More US, Malaria No More UK, KEMRI Wellcome Trust
    PDF
    lock
    Publications / Report
    Malaria Futures for Central Africa

    The MalaFA CA (Malaria Futures for Central Africa supplementary report) is the latest extension of the Malaria Futures for Africa (MalaFA) study, commissioned by Novartis, which has already conducted similar research across 15 countries in Africa. The new supplementary report involved interviews with politicians, senior civil servants, malaria program directors, researchers and NGOs in Cameroon, Democratic Republic of the Congo (DRC), Republic of Congo, and Rwanda. All four are countries that have a significant malaria burden and differing policies in place to fight the disease. Study co-chairs are Dr Richard Kamwi, Ambassador, Elimination 8 (E8), and Professor Bob Snow, of the KEMRI-Wellcome Trust programme, Kenya and University of Oxford, United Kingdom.

  • Novartis in Society 2019 US Report
    PDF
    lock
    Publications / Report
    Novartis in Society US Report 2019

    Our stakeholders have important questions about our business practices in the United States, including our approach to price adjustments, patient assistance, investment in research and development, and marketing. The Novartis in Society US report aims to help answer those questions.

  • Annual Report 2019
    PDF
    lock
    Publications / Report
    Novartis Annual Report 2019

    Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results.

  • Novartis Annual Report 2020
    PDF
    lock
    Publications / Report
    Novartis Annual Report 2020

    This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also discloses our operating and financial results, accompanied by audited annual financial statements.

  • Novartis in Society ESG Report 2020
    PDF
    lock
    Publications / Report
    Novartis in Society ESG Report 2020

    The Novartis in Society ESG Report details progress on environmental, social and governance topics and demonstrates the company’s commitment in global health and corporate responsibility.

  • Novartis is Society 2020 US Report
    PDF
    lock
    Publications / Report
    Novartis in Society US Report 2020

    Novartis is working on multiple fronts in the United States to build trust and expand access to healthcare in challenging times. The Novartis in Society US report details some of our initiatives in corporate responsibility, science & innovation, value & pricing, and responsible business practices.